Improving Knowledge and Awareness of Preventive Antibodies for Respiratory Syncytial Virus (RSV) for Infants and Young Children

To participate in this activity, please:

Log in Sign Up

Respiratory syncytial virus (RSV) is a contagious infection of the respiratory tract and one of the most common causes of illness amongst children. Prevention is a key public health goal, either through pregnant parent vaccination or RSV antibodies. This activity consists of five (5) paired conversations with experts in nursing, pediatrics, and neonatology. During these conversations, the faculty explore the basics of RSV infection and illness, currently available immunoprophylaxis strategies, and tools to assist clinicians in preventing RSV among infants and young children. In particular, the activity provides in-depth discussion of RSV antibodies, detailing clinical evidence and recommendations to support their benefits and use.  

This content is also available as a podcast:  You may listen here.

 

Course Credit:

1.00 AAPA Category I CME Credit
1.00 ACPE Contact Hour
1.00 AMA PRA Category 1 CreditTM
1.00 ANCC Contact Hour
1.00 CA-BRN Contact Hour
0.50 Pharmacology Hours

Dates:

Opens: 2026-02-17
Closes: 2027-02-17

Target Audience:

National audience of pediatricians, family medicine physicians, neonatologists, nurse practitioners, physician associates, and pharmacists who provide care to infants and young children at-risk for RSV.

This activity is supported by an educational grant from Merck Sharp & Dohme LLC.

Accreditation Information

Accreditation

In support of improving patient care, the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences at Eisenhower designates this knowledge-based activity for a maximum of 1 hour . Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

The Annenberg Center has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 hour AAPA Category 1 CME credits. Approval is valid until February 17, 2027. Physician Associates should only claim credit commensurate with the extent of their participation.

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 ANCC contact hour, including 0.5 pharmacology hours.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1 contact hour.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

Additional Content Planners

Jordan Covvey, PharmD, PhD, BCPS (Medical Writer)
No significant relationships to disclose.

Amber Lambert, MSN, FNP-C, DNP (Nurse Reviewer)
No significant relationships to disclose.

Kam A. Newman, MD (Peer Reviewer)
No significant relationships to disclose.

All of the financial relationships listed for these individuals have been mitigated.

    Presenting Faculty

  • Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP headshot

    Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP

    PUBLIC HEALTH

    Adjunct Clinical Assistant Professor
    Stony Brook University School of Nursing
    Stony Brook, New York

  • Lisa Saiman, MD, MPH headshot

    Lisa Saiman, MD, MPH

    PEDIATRIC INFECTIOUS DISEASE SPECIALIST

    Professor of Pediatrics
    Columbia University Irving Medical Center
    Pediatric Infectious Diseases
    New York, New York

  • Pablo J. Sánchez, MD headshot

    Pablo J. Sánchez, MD

    NEONATOLOGY INFECTIOUS DISEASE SPECIALIST

    Professor of Pediatrics
    Nationwide Children’s Hospital, The Ohio State University College of Medicine
    Divisions of Neonatology and Pediatric Infectious Diseases
    Center for Perinatal Research
    The Abigail Wexner Research Institute at Nationwide Children's Hospital
    Columbus, Ohio

Learning Objectives

  • Describe the burden of disease and risk factors related to RSV infection for infants and young children.
  • Utilize clinical data to provide parents with evidence-based information on RSV immunoprophylaxis.
  • Incorporate RSV preventive antibodies into preventive health recommendations for infants and young children in alignment with current evidence-based guidelines.

Faculty Disclosures

Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP

No relationships to disclose.

Lisa Saiman, MD, MPH

Data Monitoring Safety Board: Merck & Co., Inc.

Research Support: AstraZeneca, Merck & Co., Inc.


Pablo J. Sánchez, MD

Consultant: Merck Sharp & Dome